“Fear defeats more people than any other one thing in the world.” For Pui-Wah Choi, this belief is neither a slogan nor a passing thought. It is a diagnosis of what keeps millions of women from accessing care. Fear keeps women from screening. Fear sustains stigma. Fear allows preventable diseases to go undetected for years. As a Harvard-trained biomedical scientist turned FemTech founder, Choi has dedicated her career to confronting fear with proof. Through science, evidence, and human-centered design, she is building solutions that meet women where they already are.
Values Forged Early
Choi grew up in Hong Kong, where lessons about responsibility and empathy were taught not through lectures but through observation. As a child, she noticed a contradiction that stayed with her. Her father would sometimes remind her to be careful with money, yet he never hesitated to help friends or employees when they faced urgent needs. He explained that while a small sum might feel insignificant to some, to others it could be life saving. That understanding shaped how Choi views leadership today. She believes that power only has meaning when it responds to real urgency.
Her first job reflected the same grounding. As a tutor earning about four and a half dollars an hour, she learned the value of persistence and patience long before she entered a laboratory. Education became her path forward. She earned her doctorate at The Chinese University of Hong Kong, followed by postdoctoral training at Harvard Medical School. Immersed in biomedical research, she developed a rigorous scientific mindset while remaining attuned to the human consequences of delayed diagnosis and unequal access.
From Research to Responsibility
Despite a promising academic trajectory, Choi began to question whether traditional research pathways alone could address the gaps she was witnessing in women’s health. Screening for cervical cancer, particularly HPV, remained invasive, stigmatized, and inaccessible for many women. Fear and discomfort were not side effects. They were structural barriers.
In 2019, she founded WomenX Biotech Limited with a clear purpose. Build evidence based innovations that remove barriers to care without compromising scientific rigor. That vision led to the launch of PadX HPV, a sanitary pad capable of detecting HPV from menstrual blood. Clinical studies demonstrated an accuracy rate of 99.2 percent, while real world deployment told an equally important story. More than half of PadX users had never undergone cervical cancer screening before.
For Choi, that statistic was not just a market insight. It was confirmation that fear can be reduced when dignity and convenience are built into the solution. WomenX has since served more than one thousand women, reduced screening barriers by sixty five percent, and distributed over sixteen thousand sanitary pads to women lacking access to basic menstrual products. The company’s products are now available through major retail and institutional channels across Hong Kong, with global expansion underway.
The journey has not been easy. Choi has spoken candidly about the realities of entrepreneurship. The long hours. The self funding. The factory floors and mall kiosks. The countless pitches required to prove demand. She often reminds younger founders that there is no easy way to achieve a meaningful dream because meaningful dreams disrupt social norms. Her advice to the next generation is simple and uncompromising. Identify what you envision, seize every opportunity to pursue it, and chase it with determination.
Science With Conscience
What sets Choi apart is not only the novelty of her technology but the way she integrates impact into business design. Inspired by her family’s experience and the challenges faced by women who leave the workforce to care for others, she has embedded job creation into WomenX projects. The company has created flexible employment opportunities for low income women and single mothers, allowing them to regain economic participation without sacrificing caregiving responsibilities.
Choi openly acknowledges the tension this creates. Giving resources to those in need while ensuring the company remains sustainable is an ongoing challenge. Yet she sees this balance as central to leadership rather than a distraction from it. She believes that businesses must address urgent societal needs while maintaining operational discipline. One without the other is incomplete.
Her thought leadership reflects the same philosophy. Whether speaking on global panels, engaging with policymakers, or reflecting publicly on power and hope, Choi consistently returns to accountability. She has argued that innovation ecosystems should not only celebrate wins but also stand with founders during uncertainty. In biotech and FemTech, where underinvestment remains common, resilience is not optional. It is structural.
Media recognition from outlets including Bloomberg News has amplified her message, but Choi remains focused on evidence. She emphasizes that scientific rigor is non negotiable and that patient safety must never be compromised. Screening tools must be validated, pathways clarified, and data shared transparently. For her, credibility is the foundation of trust.
Vision for the Future
Today, Choi is leading WomenX into its next phase. With PadX HPV launched in Hong Kong, her focus is on global partnerships, regulatory expansion, and investment aligned with mission. She is actively seeking collaborators who understand that women’s health innovation requires both courage and patience.
At the heart of her leadership is a refusal to let fear dictate outcomes. Fear of failure. Fear of stigma. Fear of challenging entrenched systems. By replacing fear with proof and power with hope, Pui-Wah Choi is redefining what it means to lead in healthcare innovation.
Editorial Note
Pui-Wah Choi’s journey is a reminder that leadership is not measured by visibility alone, but by the lives quietly changed through principled action. As WomenX Biotech expands globally, her work invites investors, partners, and policymakers to reconsider how science, dignity, and impact can coexist. The future of women’s health will belong to those willing to build it with evidence, empathy, and resolve.
